Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Gap Insider Sold Shares Worth $22,070,868, According to a Recent SEC Filing

Gap Insider Sold Shares Worth $22,070,868, According to a Recent SEC Filing

MT newswireMT newswire2026/10/07 21:00

05:00 PM EDT, 10/07/2026 (MT Newswires) -- William Sydney Fisher, 10% Owner, Director, on October 05, 2026, sold 933,656 shares in Gap (GAP) for $22,070,868. Following the Form 4 filing with the SEC, Fisher has control over a total of 33,818,463 common shares of the company, with 15,903,198 shares held directly and 17,915,265 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/39911/000121708126000015/xslF345X05/form4-10072026_081018.xml

05:00 PM EDT, 10/07/2026 (MT Newswires) -- William Sydney Fisher, 10% Owner, Director, on October 05, 2026, sold 933,656 shares in Gap (GAP) for $22,070,868. Following the Form 4 filing with the SEC, Fisher has control over a total of 33,818,463 common shares of the company, with 15,903,198 shares held directly and 17,915,265 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/39911/000121708126000015/xslF345X05/form4-10072026_081018.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21